We've compiled our annual #BestofBiz 2025 lists across all our industries, featuring our most popular articles, most-read ...

The new "triple agonist" weight loss medication called retatrutide can help people lose an average of 28.7 percent of ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Retatrutide, a new experimental weight-loss drug, targets three hormones and shows promising results far beyond current ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Investing.com -- WW International Inc (NASDAQ:WW) stock jumped 11.5% Tuesday after the company, formerly known as Weight Watchers, announced a new integrated program providing comprehensive support ...

The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...

Biotech innovator accelerated growth in 2025, doubled headcount, and expanded operations in the US The Cradle platform provides AI protein design tools trained on unique customer data and tailored for ...

Judge refuses to grant Sarah Palin a new trial in her libel lawsuit against the New York Times Nick Reiner revealed violent ...

Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response ...